Memantine an Neramexane have been in studies since about 2009 (what's taking so long) but reduced chronic tinnitus in rats -
Study. Glad to see that companies are doing more research in this area.
More about Neramexane-
Neramexane is expected to improve the patients' psychological
suffering and difficulties in their life associated with tinnitus by inhibiting the excessive
excitation in the auditory pathway from the inner ear to nerve and cerebral cortex via mainly
its two pharmacological properties.
1) Neramexane inhibits the excessive nerve excitation in the auditory pathway between the
inner ear and cerebral cortex via NMDA antagonistic activity.
2) Neramexane inhibits the nerve excitation in the inner ear via nicotinic acetylcholine
receptor antagonistic activity.
Expected Indications: Alleviation of the psychological suffering and difficulties in the life
associated with tinnitus in patients suffering from moderate to severe tinnitus
* About NMDA antagonist: "NMDA receptor" is a receptor that receives glutamic acid in
the nerve system which transmits signals between the nerves via glutamic acid, a kind of
amino acid. NMDA antagonist inhibits the excessive excitation of brain cells and nerve
variation.
About nicotinic acetylcholine receptor antagonist: "Nicotinic receptor" is one of two
receptors which acetylcholine binds to. It is known that a lot of nicotinic receptors
categorized α9 and α10 exist in the inner ear. Nicotinic acetylcholine receptor antagonist
inhibits the nerve excitation mainly in the inner ear.